View in EDS PDF Full Text

Retargeted adenoviruses for local IgA and CD47 blocker production as a novel cancer therapy.

Saved in:
Bibliographic Details
Title: Retargeted adenoviruses for local IgA and CD47 blocker production as a novel cancer therapy.
Authors: Chernyavska M; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Hartmann KP; Department of Biochemistry, University of Zurich, Zurich, Switzerland., Jansen JHM; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Baumann N; Division of Stem Cell Transplantation and Cellular Immunotherapies, Department of Medicine II, University Medical Center Schleswig-Holstein and Christian-Albrechts-University, Kiel, Germany., Kolibius J; Department of Biochemistry, University of Zurich, Zurich, Switzerland., Brücher D; Department of Biochemistry, University of Zurich, Zurich, Switzerland., Kristoforus T; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Peters RHW; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Huijs L; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Laarveld D; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Weiss F; Department of Biochemistry, University of Zurich, Zurich, Switzerland., Burger R; Division of Stem Cell Transplantation and Cellular Immunotherapies, Department of Medicine II, University Medical Center Schleswig-Holstein and Christian-Albrechts-University, Kiel, Germany., Lustig M; Division of Stem Cell Transplantation and Cellular Immunotherapies, Department of Medicine II, University Medical Center Schleswig-Holstein and Christian-Albrechts-University, Kiel, Germany., Gimenez de Assis N; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Schmid M; Department of Biochemistry, University of Zurich, Zurich, Switzerland., Leusen JHW; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands., Valerius T; Division of Stem Cell Transplantation and Cellular Immunotherapies, Department of Medicine II, University Medical Center Schleswig-Holstein and Christian-Albrechts-University, Kiel, Germany., Plückthun A; Department of Biochemistry, University of Zurich, Zurich, Switzerland., Verdurmen WPR; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands. Wouter.Verdurmen@radboudumc.nl.
Source: EMBO molecular medicine [EMBO Mol Med] 2026 Jul 07. Date of Electronic Publication: 2026 Jul 07.
Publication Type: Journal Article
Journal Info: Publisher: EMBO Press Country of Publication: Germany NLM ID: 101487380 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-4684 (Electronic) Linking ISSN: 17574676 NLM ISO Abbreviation: EMBO Mol Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42414574
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Retargeted adenoviruses for local IgA and CD47 blocker production as a novel cancer therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chernyavska+M%22">Chernyavska M</searchLink>; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hartmann+KP%22">Hartmann KP</searchLink>; Department of Biochemistry, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Jansen+JHM%22">Jansen JHM</searchLink>; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Baumann+N%22">Baumann N</searchLink>; Division of Stem Cell Transplantation and Cellular Immunotherapies, Department of Medicine II, University Medical Center Schleswig-Holstein and Christian-Albrechts-University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Kolibius+J%22">Kolibius J</searchLink>; Department of Biochemistry, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Brücher+D%22">Brücher D</searchLink>; Department of Biochemistry, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kristoforus+T%22">Kristoforus T</searchLink>; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Peters+RHW%22">Peters RHW</searchLink>; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Huijs+L%22">Huijs L</searchLink>; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Laarveld+D%22">Laarveld D</searchLink>; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Weiss+F%22">Weiss F</searchLink>; Department of Biochemistry, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Burger+R%22">Burger R</searchLink>; Division of Stem Cell Transplantation and Cellular Immunotherapies, Department of Medicine II, University Medical Center Schleswig-Holstein and Christian-Albrechts-University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Lustig+M%22">Lustig M</searchLink>; Division of Stem Cell Transplantation and Cellular Immunotherapies, Department of Medicine II, University Medical Center Schleswig-Holstein and Christian-Albrechts-University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Gimenez+de+Assis+N%22">Gimenez de Assis N</searchLink>; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Schmid+M%22">Schmid M</searchLink>; Department of Biochemistry, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Leusen+JHW%22">Leusen JHW</searchLink>; Center for Translational Immunology, UMC Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Valerius+T%22">Valerius T</searchLink>; Division of Stem Cell Transplantation and Cellular Immunotherapies, Department of Medicine II, University Medical Center Schleswig-Holstein and Christian-Albrechts-University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Plückthun+A%22">Plückthun A</searchLink>; Department of Biochemistry, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Verdurmen+WPR%22">Verdurmen WPR</searchLink>; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands. Wouter.Verdurmen@radboudumc.nl.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101487380%22">EMBO molecular medicine</searchLink> [EMBO Mol Med] 2026 Jul 07. <i>Date of Electronic Publication: </i>2026 Jul 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22EMBO+Press%22">EMBO Press </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101487380 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1757-4684 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217574676%22">17574676 </searchLink><i>NLM ISO Abbreviation: </i>EMBO Mol Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42414574
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s44321-026-00477-7
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Retargeted adenoviruses for local IgA and CD47 blocker production as a novel cancer therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chernyavska M
      – PersonEntity:
          Name:
            NameFull: Hartmann KP
      – PersonEntity:
          Name:
            NameFull: Jansen JHM
      – PersonEntity:
          Name:
            NameFull: Baumann N
      – PersonEntity:
          Name:
            NameFull: Kolibius J
      – PersonEntity:
          Name:
            NameFull: Brücher D
      – PersonEntity:
          Name:
            NameFull: Kristoforus T
      – PersonEntity:
          Name:
            NameFull: Peters RHW
      – PersonEntity:
          Name:
            NameFull: Huijs L
      – PersonEntity:
          Name:
            NameFull: Laarveld D
      – PersonEntity:
          Name:
            NameFull: Weiss F
      – PersonEntity:
          Name:
            NameFull: Burger R
      – PersonEntity:
          Name:
            NameFull: Lustig M
      – PersonEntity:
          Name:
            NameFull: Gimenez de Assis N
      – PersonEntity:
          Name:
            NameFull: Schmid M
      – PersonEntity:
          Name:
            NameFull: Leusen JHW
      – PersonEntity:
          Name:
            NameFull: Valerius T
      – PersonEntity:
          Name:
            NameFull: Plückthun A
      – PersonEntity:
          Name:
            NameFull: Verdurmen WPR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 07
              Text: 2026 Jul 07
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1757-4684
          Titles:
            – TitleFull: EMBO molecular medicine
              Type: main
ResultId 1